Cutaneous metastases in breast cancer

Clinical Journal of Oncology Nursing

Volumn 15, Issue 1, 2011, Pages 99-101

  Kalmykow, Brianna ^a   Walker, Suzanne ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BREAST TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SKIN TUMOR;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; SKIN NEOPLASMS;

EID: 79953097633     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/11.CJON.99-101     Document Type: Article

References (18)

1. Adderley, U., & Smith, R. (2007). Topical agents and dressings for fungating wounds. Cochrane Database of Systematic Reviews, 2, CD003948.
2. Bennett Britton, T.M., & Purushotham, A.D. (2009). Understanding breast cancer-related lymphoedema. Surgeon, 7, 120-124.
3. Conlin, A.K., & Seidman, A.D. (2008). Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer. Clinical Breast Cancer, 8, 215-223. doi: 10.3816/CBC.2008.n.024
4. Delmore, B., & Duran, D. (2009). Care of fungating breast wounds. Clinical Journal of Oncology Nursing, 13, 113-115. doi: 10.1188/09.CJON.113-115
5. Golshan, M., & Smith, B. (2006). Prevention and management of arm lymphedema in the patient with breast cancer. Journal of Supportive Oncology, 4, 381-386.
6. Gonzalez-Angulo, A.M., Morales-Vasquez, F., & Hortobagyi, G.N. (2007). Overview of resistance to systemic therapy in patients with breast cancer. Advances in Experimental Medicine and Biology, 608, 1-22.
7. Hu, S.C., Chen, G.S., Lu, Y.W., Wu, C.S., & Lan, C.C. (2008). Cutaneous metastases from different internal malignancies: A clinical and prognostic appraisal. Journal of the European Academy of Dermatology and Venereology, 22, 735-740.
8. Hussein, M.R. (2010). Skin metastasis: A pathologist's perspective. Journal of Cutaneous Pathology, 37, E1-E20. doi: 10.1111/j.1600-0560.2009.01469.x
9. Lund-Nielsen, B., Muller, K., & Adamsen, L. (2005). Malignant wounds in women with breast cancer: Feminine and sexual perspectives. Journal of Clinical Nursing, 14, 56-64. doi: 10.1111/j.1365-2702.2004.01022.x
10. Milgrom, S., & Higgins, S.A. (2009). Management of cellulitis associated with treatment of breast cancer. Journal of Supportive Oncology, 7, 174-176.
11. Moore, S. (2002). Cutaneous metastatic breast cancer. Clinical Journal of Oncology Nursing, 6, 255-260.
12. Nashan, D., Muller, M.L., Braun-Falco, M., Reichenberger, S., Szeimies, R.M., & Bruckner-Tuderman, L. (2009). Cutaneous metastases of visceral tumours: A review. Journal of Cancer Research and Clinical Oncology, 135, 1-14.
13. National Comprehensive Cancer Network. (2010). NCCN Clinical Practice Guidelines in Oncology™ Breast cancer [v.2.2010]. Retrieved from http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf
14. Nava, G., Greer, K., Patterson, J., & Lin, K.Y. (2009). Metastatic cutaneous breast carcinoma: A case report and review of the literature. Canadian Journal of Plastic Surgery, 17, 25-27.
15. Pal, S.K., Gupta, R., Somlo, G., Hurria, A., Chung, C.T., Luu, T.H., Mortimer, J. (2008). Lack of survival benefit in metastatic breast cancer with new chemotherapeutic agents: The City of Hope experience [Abstract 17510]. Retrieved from http://www.asco.org/ascov2/Meetings/Abstracts?&vmview=abst_detail_view&confID=55&abstractID=34130
16. Sagen, A., Karesen, R., & Risberg, M.A. (2009). Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up. Acta Oncologica, 48, 1102-1110.
17. Schwartz, R.A., Wiederkehr, M., & Lambert, W.C. (2004). Secondary mucinous carcinoma of the skin: Metastatic breast cancer. Dermatologic Surgery, 30(2, Part 1), 234-235.
18. Seaman, S. (2006). Management of malignant fungating wounds in advanced cancer. Seminars in Oncology Nursing, 22, 185-193.